Global Hospital Injectable Drugs Competitive Landscape Professional Research Report 2024

Research Summary

Hospital injectable drugs refer to medications that are administered through injection or infusion in a hospital or clinical setting. These drugs are typically provided in liquid form and are delivered directly into the patient's bloodstream, muscles, or other tissues, allowing for rapid absorption and therapeutic effect. Injectable drugs play a crucial role in various medical treatments, including pain management, emergency care, chemotherapy, anesthesia, and the treatment of various medical conditions. They are administered by healthcare professionals, such as nurses or physicians, and may be given through intravenous (IV) lines, intramuscular (IM) injections, or subcutaneous (SC) injections. Injectable drugs are chosen based on the specific medical condition being treated and the desired mode of administration. The use of injectable drugs in hospitals requires careful preparation, accurate dosing, and adherence to safety protocols to ensure effective and safe patient care.

According to DIResearch's in-depth investigation and research, the global Hospital Injectable Drugs market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Hospital Injectable Drugs include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Otsuka, B.Braun, JW Life Science, Auromedics, Gland Pharma, Sanofi, Endo International PLC, Sichuan Kelun Pharmaceutical, Cisen Pharmaceutical, Shijiazhuang No. 4 Pharmaceutical, Shandong Hualu Pharmaceutical, CR Double-Crane etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Hospital Injectable Drugs. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Hospital Injectable Drugs market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Hospital Injectable Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Hospital Injectable Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Hospital Injectable Drugs Include:

Hospira (Pfizer Inc.)

Baxter

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy's Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Otsuka

B.Braun

JW Life Science

Auromedics

Gland Pharma

Sanofi

Endo International PLC

Sichuan Kelun Pharmaceutical

Cisen Pharmaceutical

Shijiazhuang No. 4 Pharmaceutical

Shandong Hualu Pharmaceutical

CR Double-Crane

Hospital Injectable Drugs Product Segment Include:

Generic Sterile Injectables

Sterile Intravenous (IV) Solutions

Hospital Injectable Drugs Product Application Include:

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Hospital Injectable Drugs Industry PESTEL Analysis

Chapter 3: Global Hospital Injectable Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Hospital Injectable Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Hospital Injectable Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Hospital Injectable Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Hospital Injectable Drugs Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Hospital Injectable Drugs Market Overview

1.1 Product Definition and Statistical Scope

1.2 Hospital Injectable Drugs Product by Type

1.2.1 Global Hospital Injectable Drugs Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Generic Sterile Injectables

1.2.3 Sterile Intravenous (IV) Solutions

1.3 Hospital Injectable Drugs Product by Application

1.3.1 Global Hospital Injectable Drugs Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Oncology

1.3.3 Anesthesia

1.3.4 Anti-Infectives

1.3.5 Parenteral Nutrition

1.3.6 Cardiovascular Diseases

1.4 Global Hospital Injectable Drugs Market Revenue Analysis (2019-2030)

1.5 Hospital Injectable Drugs Market Development Status and Trends

1.5.1 Hospital Injectable Drugs Industry Development Status Analysis

1.5.2 Hospital Injectable Drugs Industry Development Trends Analysis

2 Hospital Injectable Drugs Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Hospital Injectable Drugs Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Hospital Injectable Drugs Market Analysis by Regions

4.1 Hospital Injectable Drugs Overall Market: 2023 VS 2024 VS 2030

4.2 Global Hospital Injectable Drugs Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Hospital Injectable Drugs Revenue and Market Share by Region (2019-2024)

4.2.2 Global Hospital Injectable Drugs Revenue Forecast by Region (2025-2030)

5 Global Hospital Injectable Drugs Market Size by Type and Application

5.1 Global Hospital Injectable Drugs Market Size by Type

5.2 Global Hospital Injectable Drugs Market Size by Application

6 North America

6.1 North America Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Hospital Injectable Drugs Market Size by Type

6.4 North America Hospital Injectable Drugs Market Size by Application

6.5 North America Hospital Injectable Drugs Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Hospital Injectable Drugs Market Size by Type

7.4 Europe Hospital Injectable Drugs Market Size by Application

7.5 Europe Hospital Injectable Drugs Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Hospital Injectable Drugs Market Size by Type

8.4 China Hospital Injectable Drugs Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Hospital Injectable Drugs Market Size by Type

9.4 APAC (excl. China) Hospital Injectable Drugs Market Size by Application

9.5 APAC (excl. China) Hospital Injectable Drugs Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Hospital Injectable Drugs Market Size by Type

10.4 Latin America Hospital Injectable Drugs Market Size by Application

10.5 Latin America Hospital Injectable Drugs Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Hospital Injectable Drugs Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Hospital Injectable Drugs Market Size by Type

11.4 Middle East & Africa Hospital Injectable Drugs Market Size by Application

11.5 Middle East & Africa Hospital Injectable Drugs Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Hospital Injectable Drugs Market Revenue by Key Manufacturers (2020-2024)

12.2 Hospital Injectable Drugs Competitive Landscape Analysis and Market Dynamic

12.2.1 Hospital Injectable Drugs Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Hospira (Pfizer Inc.)

13.1.1 Hospira (Pfizer Inc.) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product Portfolio

13.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Baxter

13.2.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Baxter Hospital Injectable Drugs Product Portfolio

13.2.3 Baxter Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Fresenius Kabi

13.3.1 Fresenius Kabi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Fresenius Kabi Hospital Injectable Drugs Product Portfolio

13.3.3 Fresenius Kabi Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Sandoz (Novartis)

13.4.1 Sandoz (Novartis) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Sandoz (Novartis) Hospital Injectable Drugs Product Portfolio

13.4.3 Sandoz (Novartis) Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Hikma Pharmaceuticals PLC

13.5.1 Hikma Pharmaceuticals PLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product Portfolio

13.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Dr. Reddy's Laboratories Ltd

13.6.1 Dr. Reddy's Laboratories Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Product Portfolio

13.6.3 Dr. Reddy's Laboratories Ltd Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Grifols

13.7.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Grifols Hospital Injectable Drugs Product Portfolio

13.7.3 Grifols Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Nichi-Iko Group (Sagent)

13.8.1 Nichi-Iko Group (Sagent) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product Portfolio

13.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Teva Pharmaceutical

13.9.1 Teva Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Teva Pharmaceutical Hospital Injectable Drugs Product Portfolio

13.9.3 Teva Pharmaceutical Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Otsuka

13.10.1 Otsuka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Otsuka Hospital Injectable Drugs Product Portfolio

13.10.3 Otsuka Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 B.Braun

13.11.1 B.Braun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 B.Braun Hospital Injectable Drugs Product Portfolio

13.11.3 B.Braun Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 JW Life Science

13.12.1 JW Life Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 JW Life Science Hospital Injectable Drugs Product Portfolio

13.12.3 JW Life Science Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Auromedics

13.13.1 Auromedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Auromedics Hospital Injectable Drugs Product Portfolio

13.13.3 Auromedics Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Gland Pharma

13.14.1 Gland Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Gland Pharma Hospital Injectable Drugs Product Portfolio

13.14.3 Gland Pharma Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Sanofi

13.15.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Sanofi Hospital Injectable Drugs Product Portfolio

13.15.3 Sanofi Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Endo International PLC

13.16.1 Endo International PLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Endo International PLC Hospital Injectable Drugs Product Portfolio

13.16.3 Endo International PLC Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Sichuan Kelun Pharmaceutical

13.17.1 Sichuan Kelun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product Portfolio

13.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.18 Cisen Pharmaceutical

13.18.1 Cisen Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Cisen Pharmaceutical Hospital Injectable Drugs Product Portfolio

13.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.19 Shijiazhuang No. 4 Pharmaceutical

13.19.1 Shijiazhuang No. 4 Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.19.2 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product Portfolio

13.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.20 Shandong Hualu Pharmaceutical

13.20.1 Shandong Hualu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.20.2 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product Portfolio

13.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.21 CR Double-Crane

13.21.1 CR Double-Crane Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.21.2 CR Double-Crane Hospital Injectable Drugs Product Portfolio

13.21.3 CR Double-Crane Hospital Injectable Drugs Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Hospital Injectable Drugs Industry Chain Analysis

14.2 Hospital Injectable Drugs Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Hospital Injectable Drugs Typical Downstream Customers

14.4 Hospital Injectable Drugs Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support